CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.
Industry, Sector and Symbol
Stock Exchange TSE
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolTSE:CRH
CUSIPN/A
Phone+1-604-6331440
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins14.77%
Return on Equity13.79%
Return on Assets7.35%
Miscellaneous
EmployeesN/A
Outstanding Shares72,907,000
Market CapC$265.06 million
CRH Medical (TSE:CRH) Frequently Asked Questions
What is CRH Medical's stock symbol?
CRH Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRH."
How were CRH Medical's earnings last quarter?
CRH Medical Corp (TSE:CRH) issued its quarterly earnings results on Wednesday, August, 1st. The company reported $0.02 earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of $0.02. The firm had revenue of $35.27 million for the quarter, compared to analysts' expectations of $33.15 million. CRH Medical had a return on equity of 13.79% and a net margin of 14.77%. View CRH Medical's Earnings History.
When is CRH Medical's next earnings date?
What price target have analysts set for CRH?
4 analysts have issued twelve-month price objectives for CRH Medical's stock. Their predictions range from C$4.25 to C$5.50. On average, they expect CRH Medical's stock price to reach C$4.94 in the next twelve months. This suggests that the stock has a possible downside of 3.9%. View Analyst Price Targets for CRH Medical.
What is the consensus analysts' recommendation for CRH Medical?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CRH Medical.
Who are some of CRH Medical's key competitors?
Some companies that are related to CRH Medical include Advanced Medical Solutions (AMS), TransEnterix (TRXC), CRH Medical (CRHM), Tristel (TSTL), TSO3 (TOS), Clover (CLV), Bovie Medical (BVX), InfuSystem (INFU), Retractable Technologies (RVP), Milestone Scientific (MLSS), IsoRay (ISR), Akers Biosciences (AKR), Daxor (DXR), Omega Diagnostics Group (ODX) and Relevium Technologies (RLV).
Who are CRH Medical's key executives?
CRH Medical's management team includes the folowing people:
- Mr. Edward Wright, CEO & Non-Independent Director (Age 55)
- Mr. Richard K. Bear, CFO & Corp. Sec. (Age 55)
- Mr. James Kreger, Pres of CRH Anesthesia Management
- Ms. Kettina Cordero, Director of Investor Relations
- Dr. Mitchel Guttenplan M.D., FACS, Medical Director
Has CRH Medical been receiving favorable news coverage?
News stories about CRH stock have been trending very positive recently, according to Accern. The research firm scores the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CRH Medical earned a media and rumor sentiment score of 0.52 on Accern's scale. They also gave headlines about the company an impact score of 48.56 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View Recent Headlines for CRH Medical.
How do I buy shares of CRH Medical?
Shares of CRH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is CRH Medical's stock price today?
One share of CRH stock can currently be purchased for approximately C$5.14.
How big of a company is CRH Medical?
CRH Medical has a market capitalization of C$265.06 million.
How can I contact CRH Medical?
CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.
MarketBeat Community Rating for CRH Medical (TSE CRH)
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe CRH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRH will underperform the S&P 500 over the long term. You may vote once every thirty days.
